Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center

被引:122
作者
Barchetti, Giovanni [1 ]
Simone, Giuseppe [2 ]
Ceravolo, Isabella [1 ]
Salvo, Vincenzo [1 ]
Campa, Riccardo [1 ]
Del Giudice, Francesco [3 ]
De Berardinis, Ettore [3 ]
Buccilli, Dorelsa [1 ]
Catalano, Carlo [1 ]
Gallucci, Michele [2 ]
Catto, James W. F. [4 ]
Panebianco, Valeria [1 ]
机构
[1] Sapienza Univ Rome, Dept Radiol Sci Oncol & Pathol, Rome, Italy
[2] Regina Elena Inst Canc Res, Dept Urol, Rome, Italy
[3] Sapienza Univ Rome, Dept Gynecol Obstetr & Urol Sci, Rome, Italy
[4] Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England
关键词
Urinary bladder neoplasms; Magnetic resonance imaging; Neoplasm grading; Diffusion magnetic resonance imaging; Neoplasm staging; UROTHELIAL CARCINOMA; EAU GUIDELINES; HIGH-GRADE; CANCER; STAGE; PERFORMANCE; NONMUSCLE;
D O I
10.1007/s00330-019-06117-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To evaluate accuracy and inter-observer variability using Vesical Imaging-Reporting and Data System (VI-RADS) for discrimination between non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Methods Between September 2017 and July 2018, 78 patients referred for suspected bladder cancer underwent multiparametric MRI of the bladder (mpMRI) prior to transurethral resection of bladder tumor (TURBT). All mpMRI were reviewed by two radiologists, who scored each lesion according to VI-RADS. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each VI-RADS cutoff. Receiver operating characteristics curves were used to evaluate the performance of mpMRI. The statistics was used to estimate inter-reader agreement. Results Seventy-five patients were included in the final analysis, 53 with NMIBC and 22 with MIBC. Sensitivity and specificity were 91% and 89% for reader 1 and 82% and 85% for reader 2 respectively when the cutoff VI-RADS > 2 was used to define MIBC. At the same cutoff, PPV and NPV were 77% and 96% for reader 1 and 69% and 92% for reader 2. When the cutoff VI-RADS > 3 was used, sensitivity and specificity were 82% and 94% for reader 1 and 77% and 89% for reader 2. Corresponding PPV and NPV were 86% and 93% for reader 1 and 74% and 91% for reader 2. Area under curve was 0.926 and 0.873 for reader 1 and 2 respectively. Inter-reader agreement was good for the overall score ( = 0.731). Conclusions VI-RADS is accurate in differentiating MIBC from NMIBC. Inter-reader agreement is overall good.
引用
收藏
页码:5498 / 5506
页数:9
相关论文
共 24 条
[1]  
[Anonymous], EUR UROL
[2]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].
Babjuk, Marko ;
Boehle, Andreas ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Hernandez, Virginia ;
Kaasinen, Eero ;
Palou, Joan ;
Roupret, Morgan ;
van Rhijn, Bas W. G. ;
Shariat, Shahrokh F. ;
Soukup, Viktor ;
Sylvester, Richard J. ;
Zigeuner, Richard .
EUROPEAN UROLOGY, 2017, 71 (03) :447-461
[3]   Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis [J].
Crozier, Jack ;
Papa, Nathan ;
Perera, Marlon ;
Ngo, Brian ;
Bolton, Damien ;
Sengupta, Shomik ;
Lawrentschuk, Nathan .
WORLD JOURNAL OF UROLOGY, 2019, 37 (04) :667-690
[4]   Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018 [J].
Cumberbatch, Marcus George Kwesi ;
Jubber, Ibrahim ;
Black, Peter C. ;
Esperto, Francesco ;
Figueroa, Jonine D. ;
Kamat, Ashish M. ;
Kiemeney, Lambertus ;
Lotan, Yair ;
Pang, Karl ;
Silverman, Debra T. ;
Znaor, Ariana ;
Catto, James W. F. .
EUROPEAN UROLOGY, 2018, 74 (06) :784-795
[5]   Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis [J].
Gandhi, Niket ;
Krishna, Satheesh ;
Booth, Christopher M. ;
Breau, Rodney H. ;
Flood, Trevor A. ;
Morgan, Scott C. ;
Schieda, Nicola ;
Salameh, Jean-Paul ;
McGrath, Trevor A. ;
McInnes, Matthew D. F. .
BJU INTERNATIONAL, 2018, 122 (05) :744-753
[6]   Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series [J].
Gendy, Rasha ;
Delprado, Warick ;
Brenner, Phillip ;
Brooks, Andrew ;
Coombes, Graham ;
Cozzi, Paul ;
Nash, Peter ;
Patel, Manish I. .
BJU INTERNATIONAL, 2016, 117 :54-59
[7]   Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer [J].
Hollenbeck, Brent K. ;
Ye, Zaojun ;
Dunn, Rodney L. ;
Montie, James E. ;
Birkmeyer, John D. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (08) :571-580
[8]   The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis [J].
Huang, Li ;
Kong, Qingcong ;
Liu, Zhenzhen ;
Wang, Jin ;
Kang, Zhuang ;
Zhu, Yeqing .
RADIOLOGY, 2018, 286 (02) :502-511
[9]   Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations [J].
Klaassen, Zachary ;
Kamat, Ashish M. ;
Kassouf, Wassim ;
Gontero, Paolo ;
Villavicencio, Humberto ;
Bellmunt, Joaquim ;
van Rhijn, Bas W. G. ;
Hartmann, Arndt ;
Catto, James W. F. ;
Kulkarni, Girish S. .
EUROPEAN UROLOGY, 2018, 74 (05) :597-608
[10]   Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5 [J].
Marcos-Gragera, Rafael ;
Mallone, Sandra ;
Kiemeney, Lambertus A. ;
Vilardell, Loreto ;
Malats, Nuria ;
Allory, Yves ;
Sant, Milena .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (15) :2217-2230